Nolatrexed dihydrochloride
Nolatrexed dihydrochloride Basic information
- Product Name:
- Nolatrexed dihydrochloride
- Synonyms:
-
- Nolatrexed hydrochloride
- Nolatrexed (AG-337)
- 3,4-Dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazoline dihydrochloride Nolatrexed (AG-337)
- Nolatrexed dihydrochloride 3,4-Dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazoline dihydrochloride
- Nolatrexed 2hydrochloride
- NOLATREXED DIHYDROCHLORIDE
- NOLATREXED HCL
- AG 337
- CAS:
- 152946-68-4
- MF:
- C14H14Cl2N4OS
- MW:
- 357.26
- EINECS:
- 680-267-3
- Product Categories:
-
- Inhibitors
- Bases & Related Reagents
- Heterocycles
- Nucleotides
- Sulfur & Selenium Compounds
- Anti-cancer&immunity
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Mol File:
- 152946-68-4.mol
Nolatrexed dihydrochloride Chemical Properties
- Melting point:
- 301-3020C
- storage temp.
- Hygroscopic, -20°C Freezer, Under Inert Atmosphere
- solubility
- Methanol, Water
- form
- Solid
- pka
- 4.1; 5.9; 9.8(at 25℃)
- color
- Off-White to Pale Yellow
- Stability:
- Hygroscopic
- CAS DataBase Reference
- 152946-68-4(CAS DataBase Reference)
Nolatrexed dihydrochloride Usage And Synthesis
Chemical Properties
Tan Solid
Uses
Antifolate thymidylate synthase inhibitor. Antineoplastic.
Biological Activity
thymidylate synthase (ts) is a crucial enzyme in the synthesis of 2'-deoxythymidine-5'-monophosphate, an essential precursor for dna biosynthesis. thus, this enzyme is a critical target in cancer chemotherapy. nolatrexed (ag-337) is a non-classical thymidylate synthase inhibitor.
in vitro
nolatrexed was designed using x-ray crystallographic data from the ts molecular modeling and folate binding site. it is a non-classical ts inhibitor in that it lacks a terminal glutamate side chain and is uncharged at physiological ph. nolatrexed does not require a specific transport mechanism to enter into cells and, once within the cell, is not a substrate for the enzyme folyl polyglutamate synthetase [1].
in vivo
when nolatrexed was administered to nude mice bearing bu25tk- tumor xenografts, a time-dependent increase in antitumor activity was observed [1].
IC 50
1.0, 0.81 and 1.0 μm for l1210, ccrf-cem and gc3/m tk- cell lines, respectively
References
[1] hughes an, rafi i, griffin mj, calvert ah, newell dr, calvete ja, johnston a, clendeninn n, boddy av. phase i studies with the nonclassical antifolate nolatrexed dihydrochloride (ag337, thymitaq) administered orally for 5 days. clin cancer res. 1999 jan;5(1):111-8.
[2] rafi i, boddy av, calvete ja, taylor ga, newell dr, bailey np, lind mj, green m, hines j, johnstone a, clendeninn n, calvert ah. preclinical and phase i clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors. j clin oncol. 1998 mar;16(3):1131-41.
Nolatrexed dihydrochlorideSupplier
- Tel
- sales@boylechem.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- 1-(800)-881-8210
- inquiries@lgmpharma.com
- Tel
- 021-50135380
- shchemsky@sina.com
Nolatrexed dihydrochloride(152946-68-4)Related Product Information
- 4-Dimethylaminopyridine
- Raltitrexed
- 4-AMINOAZOBENZENE HYDROCHLORIDE
- 1-AdaMantanethylaMine
- D-Glucosamine hydrochloride
- Kresoxim-methyl
- Methyl salicylate
- 3-Aminopyridine
- 4-Aminopyridine
- Pemetrexed Disodium
- Nolatrexed
- Methyl acetate
- Tribenuron methyl
- Thiophanate-methyl
- Pyridine hydrochloride
- 5-Amino-2-methylpyridine
- METSULFURON METHYL
- Pirimiphos-methyl